Ausgabe 4/2022
Inhalt (12 Artikel)
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells
Lemeng Zhang, Tianli Cheng, Hua Yang, Jianhua Chen, Xiaoping Wen, Zhou Jiang, Huihuang Yi, Yongzhong Luo
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways
Marzieh Shirin, Sajedeh Madadi, Noshad Peyravian, Zahra Pezeshkian, Leili Rejali, Masoumeh Hosseini, Afshin Moradi, Binazir Khanabadi, Ghazal Sherkat, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma
Jianpeng Li, Jinlong Cao, Cheng Liang, Ran Deng, Pan Li, Junqiang Tian
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma
Bakiye Goker Bagca, Cigir Biray Avci, Baha Sezgin, Ali Veral, Sercan Gode, Halil Bulent Karci
A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy
Xingchen Li, Zhiyi Wan, Xiu Liu, Kai Ou, Lin Yang
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma
Wanjun Chen, Weijie Liang, Yongjian He, Chixiang Liu, Hongtian Chen, Piao Lv, Yuan Yao, Huayou Zhou
ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis
Li He, Sinan Lv, Xuejiao Ma, Sufang Jiang, Fang Zhou, Yunwu Zhang, Rong Yu, Yuhua Zhao
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells
Buket Ozel, Sezgi Kipcak, Cigir Biray Avci, Cumhur Gunduz, Guray Saydam, Cagdas Aktan, Nur Selvi Gunel
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression
Yin-Ling Zhang, Jin-Ling Cao, Ye Zhang, Li Liao, Ling Deng, Shao-Ying Yang, Shu-Yuan Hu, Yan Ning, Fang-Lin Zhang, Da-Qiang Li
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer
Caroline Hamm, Bre-Anne Fifield, Amin Kay, Swati Kulkarni, Rasna Gupta, John Mathews, Rosa-Maria Ferraiuolo, Huda Al-Wahsh, Emily Mailloux, Abdulkadir Hussein, Lisa A. Porter
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives
Jędrzej Borowczak, Krzysztof Szczerbowski, Navid Ahmadi, Łukasz Szylberg
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer
Chinmoy K. Bose